Out-licensing: Biotechnology & Oncology

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..10 of 239 - per page Next page
Order by

Cellophil(TM) Biomedical Polymer - New and superior biomedical polymers for a new standard in the medical device industry.

Cellophil (TM) is particularly designed for optical lenses, drug delivery and also may be used as additive for food and cosmetics or as fiber for fabrics. More

Erythropoietin

rHu EPO More

Micro Fine, Dry Powder Pulmonary Drug Delivery Technology Suite

Researchers at the University of Western Ontario have developed a Pulmonary Drug Delivery Technology Suite comprised of two innovative inventions for the precision measurement and dispensing of micro fine, dry powders. More

Golden Biotechnology: Antroquinonol®, a new chemical entity with application in cancer therapy and auto-immune disease therapy

Antroquinonol® is a non-toxic, highly effective cancer treatment agent, developed using natural organic chemistry. More

Pegylated Filgrastim

Peg GCSF More

Granulocyte colony stimulating factor

rHu G-CSF More

Retinoid Acid Receptor Antagonists in Bone and Cartilage Repair

Identification and use of RAR antagonists to induce bone and cartilage formation More

In Vivo Non-Invasive Diagnostic Method Using Magnetic Resonance Spectroscopy of Aspartate Transaminase

A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More

Timerx Technology, Geminex, SyncroDose, and GastroDose

The matrix consists of two polysaccharides, xanthan and locus More

Diagnostic Method to Detect Endometriosis

A non-invasive development of a test for the diagnosis and monitoring of endometriosis. More

Displaying 1..10 of 239 - per page Next page
Order by

Your selection

Industry sector: Biotechnology del
Therapeutic target: Oncology del

Browse By

Industry sector: Assay systems; Diagnostic test systems; Gene therapy; Human diagnostics; Human therapeutics; Nanotechnology; Other; Research supplies; Stem cells
Therapeutic target: Anti-oxidant; Bladder cancer; Bone cancer; Brain cancer; Breast cancer; Cancer (other); Cancer side effects; Cervical cancer; Colorectal cancer; Head and neck cancer; Kaposi's sarcoma; Kidney cancer; Leukemia; Liver cancer; Lung cancer; Lymphoma; Ovarian cancer; Pancreatic cancer; Polyps; Prostate cancer; Skin cancer; Stomach/Esophageal; Testicular cancer; Transplant; Treatments; Tumor (other); Vaginal Cancer; Womb cancer
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us